Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

AstraZeneca Settles Federal Fraud Suit for $520M

April 28, 2010 5:44 am | by Pete Yost | News | Comments

The federal government reached a $520 million settlement with pharmaceutical manufacturer AstraZeneca, resolving allegations of illegal marketing of the company's antipsychotic drug Seroquel.


Judge Rejects Guidant Plea Deal

April 28, 2010 5:40 am | by Amy Forliti | News | Comments

A federal judge rejected a plea deal by Boston Scientific Corp.'s Guidant unit to pay $296 million for failing to properly disclose changes made to some implantable heart devices, saying it didn't adequately address the company's criminal conduct.


FDA Warns Teva Over Manufacturing Issues

April 28, 2010 5:37 am | News | Comments

Federal regulators say Teva Pharmaceutical Industries Ltd.'s Parenteral Medicines unit failed to correct manufacturing problems at its Irvine, Calif. facility that caused contamination in batches of an anesthetic.


Supreme Court Says Vioxx Lawsuit Can Proceed

April 28, 2010 5:34 am | by Jesse J. Holland | News | Comments

A unanimous Supreme Court said investors who lost millions betting on the blockbuster drug Vioxx can sue Merck & Co. over whether the pharmaceutical giant provided enough information about the painkiller's risks before it was pulled from the market.


GSK Profits Up 19% In First Quarter

April 28, 2010 5:30 am | News | Comments

GlaxoSmithKline, the world's second-largest drug maker by revenue, reported a nearly 19 percent rise in first quarter profit, led by strong sales growth in Asia Pacific and emerging markets.


Evotec Receives Funding From BMBF

April 27, 2010 8:37 am | News | Comments

Evotec AG announced that it will receive funding of up to EUR 1.5 million from the German Federal Ministry of Education and Research (BMBF) to advance its H3 receptor antagonist programme into the clinic.



April 27, 2010 8:06 am | Product Releases | Comments

Bioo Scientific introduced a new MaxDiscovery Apolipoprotein B ELISA Kit, a complete, two-step ELISA that analyzes the quantity of ApoB in tissues, serum, plasma or cultured cells for research purposes.


Glow Dye

April 27, 2010 7:58 am | Product Releases | Comments

Glow Dyes contain an optimized concentration of buffer agents, tracking dyes and ethidium bromide and provide intense DNA/RNA bands with virtually no background or band distortion.


PPD Opens New Research Center in China

April 27, 2010 7:49 am | News | Comments

PPD, Inc. announced it has opened a vaccine clinical research center in Taizhou, China, further strengthening its clinical research and development services in one of the country's major regions for conducting vaccine studies.


Bio-Rad Collaborates With LayerLab

April 27, 2010 7:08 am | News | Comments

Bio-Rad Laboratories, Inc. is collaborating with Layerlab of Sweden to enable researchers to study the binding kinetics of any transmembrane protein using surface plasmon resonance technology.


Cellular Mechanical Forces May Initiate Angiogenesis

April 27, 2010 6:53 am | News | Comments

Pericytes, the contractile cells surrounding capillaries, may use mechanical forces to initiate angiogenesis, the "sprouting" of new blood vessels, according to researchers at Tufts University and MIT.


Mapping Calcium Channels May Be Key to Chronic Pain

April 27, 2010 6:48 am | News | Comments

In most cases of chronic pain –– lingering pain that never seems to go away after accidents or prolonged illnesses ? no pill exists to dull the hurt.


Merck Purchases Joint Marketing Rights for Daxas

April 27, 2010 6:37 am | by Linda A. Johnson | News | Comments

Drugmaker Merck & Co. said it has bought rights to help market what would be the first anti-inflammatory pill for a chronic lung condition, just a few days after European regulators recommended approval there.


Ataluren Helps Restore Protein Function in Cystic Fibrosis

April 27, 2010 6:31 am | News | Comments

Inherited diseases such as cystic fibrosis can be caused by genetic "nonsense mutations" that disrupt the way human cells make proteins. Scientists are now closer to producing drugs that will fix this disruption and drastically improve treatment of genetic disease.


Appeals Court Invalidates Concerta Patent

April 27, 2010 6:26 am | News | Comments

Watson Pharmaceuticals Inc. said that an appeals court affirmed that a disputed patent on Johnson & Johnson's attention deficit drug Concerta is invalid.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.